Spiegel BMR, Locke GR, Kurtz C, Williams VS, Nelson LM, Carson RT. Developing benchmarks for clinically meaningful change for ibs-c symptoms using data from two phase 3 trials of linaclotide. Poster presented at the 2012 Digestive Disease Week; May 2012.

Abstract not available at this time

Share on: